Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.
Artificial Intelligence (AI) has transformed various industries, and healthcare is no exception. Among the many advancements, Medical AI stands out as a game-changer, redefining the way healthcare ...
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...